Hamlet (HAMLET B) | Spotlight

Hamlet BioPharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.

Quotes for Hamlet BioPharma AB

Right Now

+/-: 0.1
%: 2,31%
Latest: 4.43
High: 4.475
Low: 4.29
Volume: 86 587
Turnover (SEK): 380 499
Market Value (MSEK): 610,1
Time (Latest trade): 2025-04-25 17:29

Board

CEO

Catharina Svanborg

Chairperson of the Board

Gabriela Godaly

Board

Bill Hansson
Catharina Svanborg
Helena Lomberg
Magnus Nylen
Ulla Trädgårdh

Articles of association

News

2025-04-22 14:38:16 Hamlet BioPharma invites to investor meeting on the 23rd of April
2025-04-09 13:35:49 New discoveries in infection biology, highlighting the rich potential of non-antibiotic treatments of infections
2025-04-08 09:52:14 New scientific advances for Alpha1H highlight the unique discovery pipeline and drug development potential for the treatment of bladder cancer
2025-04-07 16:57:08 New granted patents added to Hamlet BioPharma's extensive patent portfolio in cancer and infection
2025-04-07 16:32:05 Strong Alpha1H treatment effects confirmed in patients with bladder cancer, in final analysis. Clinical study report is being completed for submission to the FDA

News agencies

2025-04-08 10:18:48 Finwire: Hamlet Biopharma publicerar nya vetenskapliga framsteg för Alpha1H
2025-04-07 17:05:34 Finwire: Hamlet Biopharma har tilldelats tre nya patent
2025-04-07 16:38:05 Finwire: Hamlet Biopharma rapporterar positiva resultat för Alpha1H hos patienter med cancer i urinblåsan
2025-02-20 13:18:49 Direkt: STYRELSEN FÖRESLÅR INGÅ LICENSAVTAL MED LINNANE PHARMA
2025-02-20 13:18:10 Finwire: Hamlet Biopharma föreslår att bolaget ska ingå licensavtal med Linnane Pharma

Analysis

2019-05-08 SvD Börsplus: Effekt eller inte effekt – det är frågan
2017-04-05 SvD Börsplus: Tragedi eller lyckligt slut för Hamlet Pharma?

Videos

Largest Owners

Name	Capital %	Votes %	Date
Catharina Svanborg	34,29	74,91	2025-03-27
Avanza Pension	5,89	2,02	2025-03-27
Nordnet Pensionsförsäkring	5,07	1,68	2025-03-27
Rolf Karlsson	3,68	1,22	2025-03-27
Nordea Liv & Pension	2,43	0,81	2025-03-27
Hans Nygren	1,88	0,62	2025-03-27
Gramsh Gashi	1,23	0,41	2025-03-27
Creative Invest One AB	0,83	0,27	2025-03-27
Försäkringsaktiebolaget Skandia	0,71	0,24	2025-03-27
Anders Borum	0,51	0,17	2025-03-27

** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Quotes for Hamlet BioPharma AB

Right Now

Board

News

News agencies

Analysis

Videos

This is HAMLET - The movie

Hamlet Pharma - Life Sciencedagen

Intervju med styrelseordförande Catharina Svanborg

Interview with Catharina Svanborg Chairman of the Board/Founder

Largest Owners

Insider trading

Key Numbers

Upcoming reports

Annual reports, prospectus etc.